-+ 0.00%
-+ 0.00%
-+ 0.00%

Faeth Therapeutics Hosts Virtual Event on PIK-201 Phase 2 Trial Results

PUBT·11/06/2026 21:01:33
Listen to the news
Faeth Therapeutics Hosts Virtual Event on PIK-201 Phase 2 Trial Results
  • Faeth Therapeutics will host a virtual event on Nov. 9, 2026, at 8 a.m. ET.
  • The event will discuss topline Phase 2 PIK-201 results evaluating PIKTOR in advanced endometrial cancer, featuring principal investigator David Starks.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Faeth Therapeutics Inc published the original content used to generate this news brief via Business Wire (Ref. ID: 202611061600BIZWIRE_USPR_____20261106_BW335577) on November 06, 2026, and is solely responsible for the information contained therein.